var eventsData = [{"Ticker":"CCL","EffectiveDate":"2016-12-20","Type":"EarningsRelease","Title":"Before market open, CCL reports 2016 Q4's earning $0.67 per share and revenue $3935MM..","DailyReturn":0.022798,"FiveDayReturnAfter":0.025397,"FiveDayReturnBefore":-0.015659},{"Ticker":"CCL","EffectiveDate":"2016-12-19","Type":"RatingNeutral","Title":"Berenberg downgrades CCL to Hold from Buy.","DailyReturn":-0.003495,"FiveDayReturnAfter":0.029277,"FiveDayReturnBefore":-0.035104},{"Ticker":"CCL","EffectiveDate":"2016-12-16","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on CCL to Neutral.","DailyReturn":-0.027568,"FiveDayReturnAfter":-0.010439,"FiveDayReturnBefore":0.000757},{"Ticker":"CCL","EffectiveDate":"2016-11-23","Type":"RatingUpgrade","Title":"Bernstein upgrades CCL to Outperform from Market Perform. Target Price is $63; previously $52.","DailyReturn":0.010238,"FiveDayReturnAfter":-0.006978,"FiveDayReturnBefore":0.022425},{"Ticker":"CCL","EffectiveDate":"2016-11-22","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":0.016893,"FiveDayReturnAfter":0.044376,"FiveDayReturnBefore":0.009408},{"Ticker":"CCL","EffectiveDate":"2016-11-22","Type":"RatingUpgrade","Title":null,"DailyReturn":0.016893,"FiveDayReturnAfter":0.044376,"FiveDayReturnBefore":0.009408},{"Ticker":"CCL","EffectiveDate":"2016-10-04","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CCL to Neutral.","DailyReturn":0.001221,"FiveDayReturnAfter":-0.033531,"FiveDayReturnBefore":0.055663},{"Ticker":"CCL","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"HSBC initiates coverage on CCL to Buy. Target Price is $60.","DailyReturn":0.00635,"FiveDayReturnAfter":-0.022162,"FiveDayReturnBefore":0.032476},{"Ticker":"CCL","EffectiveDate":"2016-09-29","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on CCL to Hold. Target Price is $48.","DailyReturn":-0.01066,"FiveDayReturnAfter":-0.000205,"FiveDayReturnBefore":0.0626},{"Ticker":"CCL","EffectiveDate":"2016-09-27","Type":"RatingNeutral","Title":"Buckingham Research maintains CCL to Buy. Target Price is $55; previously $53.","DailyReturn":0.040456,"FiveDayReturnAfter":0.055663,"FiveDayReturnBefore":0.012343},{"Ticker":"CCL","EffectiveDate":"2016-09-26","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2016 Q3's earning $1.92 per share and revenue $5097MM. This beats analyst's estimated EPS $1.88, beats estimated revenue $5060MM.","DailyReturn":-0.016716,"FiveDayReturnAfter":0.032476,"FiveDayReturnBefore":0.021603},{"Ticker":"CCL","EffectiveDate":"2016-09-09","Type":"RatingNeutral","Title":"Bernstein initiates coverage on CCL to Outperform. Target Price is $51.","DailyReturn":-0.010923,"FiveDayReturnAfter":0.03526,"FiveDayReturnBefore":-0.063478},{"Ticker":"CCL","EffectiveDate":"2016-09-02","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CCL to Underweight from Equal-Weight. Target Price is $48; previously $54.","DailyReturn":-0.047433,"FiveDayReturnAfter":-0.093114,"FiveDayReturnBefore":0.031497},{"Ticker":"CCL","EffectiveDate":"2016-08-24","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":-0.003162,"FiveDayReturnAfter":-0.000632,"FiveDayReturnBefore":0.025645},{"Ticker":"CCL","EffectiveDate":"2016-06-29","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $52; previously $46.5.","DailyReturn":0.016922,"FiveDayReturnAfter":-0.012659,"FiveDayReturnBefore":-0.106618},{"Ticker":"CCL","EffectiveDate":"2016-06-28","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2016 Q2's earning $0.49 per share and revenue $3705MM. This beats analyst's estimated EPS $0.38, beats estimated revenue $3680MM.","DailyReturn":0.002062,"FiveDayReturnAfter":0.002516,"FiveDayReturnBefore":-0.10559},{"Ticker":"CCL","EffectiveDate":"2016-06-07","Type":"RatingNeutral","Title":"Sterne Agee CRT initiates coverage on CCL to Buy. Target Price is $60.","DailyReturn":0.009135,"FiveDayReturnAfter":-0.009178,"FiveDayReturnBefore":-0.031988},{"Ticker":"CCL","EffectiveDate":"2016-05-31","Type":"RatingUpgrade","Title":"Tigress Financial upgrades CCL to Buy from Neutral.","DailyReturn":-0.017695,"FiveDayReturnAfter":-0.031988,"FiveDayReturnBefore":-0.02209},{"Ticker":"CCL","EffectiveDate":"2016-05-26","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $54; previously $60.","DailyReturn":-0.041104,"FiveDayReturnAfter":-0.026543,"FiveDayReturnBefore":-0.007097},{"Ticker":"CCL","EffectiveDate":"2016-05-25","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":-0.016838,"FiveDayReturnAfter":-0.049334,"FiveDayReturnBefore":0.017863},{"Ticker":"CCL","EffectiveDate":"2016-04-08","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $60; previously $58.","DailyReturn":-0.000782,"FiveDayReturnAfter":0.007592,"FiveDayReturnBefore":-0.030594},{"Ticker":"CCL","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $60; previously $58.","DailyReturn":-0.01558,"FiveDayReturnAfter":-0.00598,"FiveDayReturnBefore":-0.007282},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"JP Morgan maintains CCL to Neutral. Target Price is $58; previously $57.","DailyReturn":0.007638,"FiveDayReturnAfter":-0.007282,"FiveDayReturnBefore":0.071629},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $60; previously $59.","DailyReturn":0.007638,"FiveDayReturnAfter":-0.007282,"FiveDayReturnBefore":0.071629},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $58; previously $57.","DailyReturn":0.007638,"FiveDayReturnAfter":-0.007282,"FiveDayReturnBefore":0.071629},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $53.5; previously $52.5.","DailyReturn":0.007638,"FiveDayReturnAfter":-0.007282,"FiveDayReturnBefore":0.071629},{"Ticker":"CCL","EffectiveDate":"2016-03-29","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $52.5; previously $49.5.","DailyReturn":0.012648,"FiveDayReturnAfter":0.07863,"FiveDayReturnBefore":-0.012368},{"Ticker":"CCL","EffectiveDate":"2016-02-29","Type":"RatingNeutral","Title":"Credit Suisse assumes CCL to Outperform. Target Price is $60.","DailyReturn":-0.007861,"FiveDayReturnAfter":-0.007683,"FiveDayReturnBefore":0.041177},{"Ticker":"CCL","EffectiveDate":"2016-02-17","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":0.026834,"FiveDayReturnAfter":0.072862,"FiveDayReturnBefore":0.071344},{"Ticker":"CCL","EffectiveDate":"2016-01-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $60; previously $55.3.","DailyReturn":-0.005139,"FiveDayReturnAfter":-0.045628,"FiveDayReturnBefore":0.007369},{"Ticker":"CCL","EffectiveDate":"2015-12-21","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $57; previously $54.","DailyReturn":0.029193,"FiveDayReturnAfter":0.033399,"FiveDayReturnBefore":0.03337},{"Ticker":"CCL","EffectiveDate":"2015-12-21","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $59; previously $55.","DailyReturn":0.029193,"FiveDayReturnAfter":0.033399,"FiveDayReturnBefore":0.03337},{"Ticker":"CCL","EffectiveDate":"2015-12-18","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2015 Q4's earning $0.5 per share and revenue $3711MM. This beats analyst's estimated EPS $0.42, misses estimated revenue $3720MM.","DailyReturn":0.038644,"FiveDayReturnAfter":0.070023,"FiveDayReturnBefore":-0.009858},{"Ticker":"CCL","EffectiveDate":"2015-11-25","Type":"RatingNeutral","Title":"HSBC initiates coverage on CCL to Buy. Target Price is $60.","DailyReturn":0.011907,"FiveDayReturnAfter":0.015556,"FiveDayReturnBefore":0.00917},{"Ticker":"CCL","EffectiveDate":"2015-11-18","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":0.00721,"FiveDayReturnAfter":0.00917,"FiveDayReturnBefore":-0.05613},{"Ticker":"CCL","EffectiveDate":"2015-11-04","Type":"RatingNeutral","Title":"Buckingham Research maintains CCL to Buy. Target Price is $60; previously $65.","DailyReturn":-0.003398,"FiveDayReturnAfter":0.002826,"FiveDayReturnBefore":-0.016101},{"Ticker":"CCL","EffectiveDate":"2015-10-05","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $57; previously $58.","DailyReturn":0.01246,"FiveDayReturnAfter":-0.008071,"FiveDayReturnBefore":-0.018714},{"Ticker":"CCL","EffectiveDate":"2015-09-23","Type":"RatingUpgrade","Title":"Nomura upgrades CCL to Buy from Neutral. Target Price is $62; previously $53.","DailyReturn":0.034344,"FiveDayReturnAfter":-0.031834,"FiveDayReturnBefore":-0.042275},{"Ticker":"CCL","EffectiveDate":"2015-09-23","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $61; previously $60.","DailyReturn":0.034344,"FiveDayReturnAfter":-0.031834,"FiveDayReturnBefore":-0.042275},{"Ticker":"CCL","EffectiveDate":"2015-09-21","Type":"RatingNeutral","Title":"Susquehanna maintains CCL to Positive. Target Price is $60; previously $56.","DailyReturn":0.011715,"FiveDayReturnAfter":-0.026664,"FiveDayReturnBefore":0.01334},{"Ticker":"CCL","EffectiveDate":"2015-09-18","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $53; previously $48.","DailyReturn":-0.012704,"FiveDayReturnAfter":-0.035905,"FiveDayReturnBefore":0.039054},{"Ticker":"CCL","EffectiveDate":"2015-08-19","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":-0.00381,"FiveDayReturnAfter":-0.103456,"FiveDayReturnBefore":0.01162},{"Ticker":"CCL","EffectiveDate":"2015-07-14","Type":"RatingUpgrade","Title":"Jefferies upgrades CCL to Hold from Underperform.","DailyReturn":0.007139,"FiveDayReturnAfter":0.006156,"FiveDayReturnBefore":0.048829},{"Ticker":"CCL","EffectiveDate":"2015-07-09","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $58; previously $56.","DailyReturn":0.005518,"FiveDayReturnAfter":0.057772,"FiveDayReturnBefore":-0.009359},{"Ticker":"CCL","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"Buckingham Research maintains CCL to Buy. Target Price is $60; previously $58.","DailyReturn":0.007276,"FiveDayReturnAfter":-0.00182,"FiveDayReturnBefore":0.041893},{"Ticker":"CCL","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $55; previously $53.","DailyReturn":0.007276,"FiveDayReturnAfter":-0.00182,"FiveDayReturnBefore":0.041893},{"Ticker":"CCL","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $60; previously $55.","DailyReturn":0.007276,"FiveDayReturnAfter":-0.00182,"FiveDayReturnBefore":0.041893},{"Ticker":"CCL","EffectiveDate":"2015-06-22","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades CCL to Buy from Hold. Target Price is $55.3; previously $51.","DailyReturn":0.020442,"FiveDayReturnAfter":0.033767,"FiveDayReturnBefore":0.031142},{"Ticker":"CCL","EffectiveDate":"2015-06-19","Type":"RatingNeutral","Title":"Susquehanna maintains CCL to Positive. Target Price is $56; previously $55.","DailyReturn":0.00617,"FiveDayReturnAfter":0.028789,"FiveDayReturnBefore":0.016382},{"Ticker":"CCL","EffectiveDate":"2015-05-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.012264,"FiveDayReturnAfter":-0.010868,"FiveDayReturnBefore":0.05439},{"Ticker":"CCL","EffectiveDate":"2015-05-13","Type":"RatingUpgrade","Title":"SunTrust Robinson Humphrey upgrades CCL to Buy from Neutral.","DailyReturn":-0.000655,"FiveDayReturnAfter":0.05439,"FiveDayReturnBefore":0.053823},{"Ticker":"CCL","EffectiveDate":"2015-04-29","Type":"RatingUpgrade","Title":"Tigress Financial upgrades CCL to Neutral from Underperform.","DailyReturn":-0.022457,"FiveDayReturnAfter":-0.045492,"FiveDayReturnBefore":-0.025432},{"Ticker":"CCL","EffectiveDate":"2015-04-13","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Neutral. Target Price is $53; previously $52.","DailyReturn":-0.010346,"FiveDayReturnAfter":-0.027691,"FiveDayReturnBefore":0.007477},{"Ticker":"CCL","EffectiveDate":"2015-04-07","Type":"RatingUpgrade","Title":"Wells Fargo upgrades CCL to Outperform from Market Perform.","DailyReturn":0.019891,"FiveDayReturnAfter":0.001465,"FiveDayReturnBefore":0.013492},{"Ticker":"CCL","EffectiveDate":"2015-03-30","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Outperform. Target Price is $55; previously $52.","DailyReturn":0.012734,"FiveDayReturnAfter":0.013492,"FiveDayReturnBefore":0.005106},{"Ticker":"CCL","EffectiveDate":"2015-03-30","Type":"RatingUpgrade","Title":"Numis Securities upgrades CCL to Add from Hold.","DailyReturn":0.012734,"FiveDayReturnAfter":0.013492,"FiveDayReturnBefore":0.005106},{"Ticker":"CCL","EffectiveDate":"2015-03-23","Type":"RatingNeutral","Title":"Deutsche Bank downgrades CCL to Hold from Buy. Target Price is $51; previously $48.","DailyReturn":-0.017491,"FiveDayReturnAfter":0.005106,"FiveDayReturnBefore":0.033624},{"Ticker":"CCL","EffectiveDate":"2015-03-20","Type":"RatingNeutral","Title":"Wedbush initiates coverage on CCL to Neutral. Target Price is $52.","DailyReturn":0.004285,"FiveDayReturnAfter":-0.049625,"FiveDayReturnBefore":0.030231},{"Ticker":"CCL","EffectiveDate":"2015-02-18","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.019284,"FiveDayReturnAfter":0.012696,"FiveDayReturnBefore":0.014892},{"Ticker":"CCL","EffectiveDate":"2015-01-12","Type":"RatingNeutral","Title":"Natixis downgrades CCL to Neutral from Buy.","DailyReturn":-0.000216,"FiveDayReturnAfter":-0.01831,"FiveDayReturnBefore":0.015014},{"Ticker":"CCL","EffectiveDate":"2014-12-22","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $54; previously $52.","DailyReturn":0.001563,"FiveDayReturnAfter":0.025568,"FiveDayReturnBefore":0.041948},{"Ticker":"CCL","EffectiveDate":"2014-12-17","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $48; previously $46.","DailyReturn":0.034555,"FiveDayReturnAfter":0.04932,"FiveDayReturnBefore":-0.019521},{"Ticker":"CCL","EffectiveDate":"2014-12-08","Type":"RatingNeutral","Title":"Jefferies maintains CCL to Underperform. Target Price is $36; previously $33.","DailyReturn":-0.012326,"FiveDayReturnAfter":-0.038146,"FiveDayReturnBefore":0.010363},{"Ticker":"CCL","EffectiveDate":"2014-12-05","Type":"RatingNeutral","Title":"Bank of America maintains CCL to Buy. Target Price is $53; previously $49.","DailyReturn":0.023864,"FiveDayReturnAfter":-0.001148,"FiveDayReturnBefore":0.034076},{"Ticker":"CCL","EffectiveDate":"2014-12-01","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CCL to Neutral from Buy.","DailyReturn":-0.040082,"FiveDayReturnAfter":0.010363,"FiveDayReturnBefore":0.059718},{"Ticker":"CCL","EffectiveDate":"2014-11-19","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.010233,"FiveDayReturnAfter":0.005694,"FiveDayReturnBefore":0.039571},{"Ticker":"CCL","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Outperform. Target Price is $46; previously $43.","DailyReturn":0.015058,"FiveDayReturnAfter":-0.008429,"FiveDayReturnBefore":0.025248},{"Ticker":"CCL","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $52; previously $49.","DailyReturn":0.015058,"FiveDayReturnAfter":-0.008429,"FiveDayReturnBefore":0.025248},{"Ticker":"CCL","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Bank of America maintains CCL to Buy. Target Price is $49; previously $45.5.","DailyReturn":0.015058,"FiveDayReturnAfter":-0.008429,"FiveDayReturnBefore":0.025248},{"Ticker":"CCL","EffectiveDate":"2014-09-23","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2014 Q3's earning $1.58 per share and revenue $4950MM. This beats analyst's estimated EPS $1.44, beats estimated revenue $4930MM.","DailyReturn":0.004214,"FiveDayReturnAfter":0.001485,"FiveDayReturnBefore":0.023324},{"Ticker":"CCL","EffectiveDate":"2014-09-12","Type":"RatingUpgrade","Title":"Shore Capital upgrades CCL to Buy from Hold.","DailyReturn":-0.002546,"FiveDayReturnAfter":0.02091,"FiveDayReturnBefore":0.004849},{"Ticker":"CCL","EffectiveDate":"2014-08-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.00506,"FiveDayReturnAfter":0.012177,"FiveDayReturnBefore":0.022743},{"Ticker":"CCL","EffectiveDate":"2014-08-07","Type":"RatingUpgrade","Title":"Bank of America upgrades CCL to Buy from Neutral.","DailyReturn":0.002207,"FiveDayReturnAfter":0.021294,"FiveDayReturnBefore":-0.008791},{"Ticker":"CCL","EffectiveDate":"2014-06-23","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2014 Q2's earning $0.1 per share and revenue $3630MM. This beats analyst's estimated EPS $0.02, beats estimated revenue $3610MM.","DailyReturn":0.007671,"FiveDayReturnAfter":-0.030373,"FiveDayReturnBefore":0.004871},{"Ticker":"CCL","EffectiveDate":"2014-05-21","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.016954,"FiveDayReturnAfter":0.015044,"FiveDayReturnBefore":-0.004329},{"Ticker":"CCL","EffectiveDate":"2014-05-20","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades CCL to Equal-weight from Underweight.","DailyReturn":0.008754,"FiveDayReturnAfter":0.027044,"FiveDayReturnBefore":-0.023159},{"Ticker":"CCL","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Berenberg initiates coverage on CCL to Buy. Target Price is $50.","DailyReturn":0.023822,"FiveDayReturnAfter":0.007482,"FiveDayReturnBefore":0.036656},{"Ticker":"CCL","EffectiveDate":"2014-03-26","Type":"RatingNeutral","Title":"JP Morgan maintains CCL to Neutral. Target Price is $39; previously $38.","DailyReturn":-0.009995,"FiveDayReturnAfter":0.009945,"FiveDayReturnBefore":-0.040969},{"Ticker":"CCL","EffectiveDate":"2014-03-26","Type":"RatingNeutral","Title":"Bank of America maintains CCL to Neutral. Target Price is $42.9; previously $43.6.","DailyReturn":-0.009995,"FiveDayReturnAfter":0.009945,"FiveDayReturnBefore":-0.040969},{"Ticker":"CCL","EffectiveDate":"2014-03-25","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2014 Q1's earning $0 per share and revenue $3585MM. This beats analyst's estimated EPS $-0.08, beats estimated revenue $3560MM.","DailyReturn":-0.0495,"FiveDayReturnAfter":-0.054984,"FiveDayReturnBefore":0.029944},{"Ticker":"CCL","EffectiveDate":"2014-03-20","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $49; previously $48.","DailyReturn":0.015748,"FiveDayReturnAfter":-0.044937,"FiveDayReturnBefore":0.001779},{"Ticker":"CCL","EffectiveDate":"2014-02-27","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $48; previously $43.","DailyReturn":0.005719,"FiveDayReturnAfter":-0.023647,"FiveDayReturnBefore":0.026197},{"Ticker":"CCL","EffectiveDate":"2014-02-19","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.008352,"FiveDayReturnAfter":0.014323,"FiveDayReturnBefore":-0.013738},{"Ticker":"CCL","EffectiveDate":"2014-02-11","Type":"RatingNeutral","Title":"Jefferies downgrades CCL to Underperform from Hold. Target Price is $33; previously $31.","DailyReturn":-0.000744,"FiveDayReturnAfter":-0.013738,"FiveDayReturnBefore":0.039469},{"Ticker":"CCL","EffectiveDate":"2014-02-05","Type":"RatingUpgrade","Title":"HSBC upgrades CCL to Overweight from Neutral. Target Price is $43.5; previously $33.","DailyReturn":-0.011012,"FiveDayReturnAfter":0.031013,"FiveDayReturnBefore":-0.038678},{"Ticker":"CCL","EffectiveDate":"2014-01-28","Type":"RatingUpgrade","Title":"Numis Securities upgrades CCL to Buy from Hold.","DailyReturn":0.030988,"FiveDayReturnAfter":-0.015872,"FiveDayReturnBefore":-0.04931},{"Ticker":"CCL","EffectiveDate":"2014-01-13","Type":"RatingUpgrade","Title":"SunTrust Robinson Humphrey upgrades CCL to Neutral from Reduce.","DailyReturn":0.004121,"FiveDayReturnAfter":0.002663,"FiveDayReturnBefore":0.034529},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingUpgrade","Title":"Credit Suisse upgrades CCL to Outperform from Neutral. Target Price is $43; previously $30.","DailyReturn":0.021025,"FiveDayReturnAfter":0.047225,"FiveDayReturnBefore":0.073888},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $43; previously $41.","DailyReturn":0.021025,"FiveDayReturnAfter":0.047225,"FiveDayReturnBefore":0.073888},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Nomura maintains CCL to Neutral. Target Price is $36; previously $32.","DailyReturn":0.021025,"FiveDayReturnAfter":0.047225,"FiveDayReturnBefore":0.073888},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingUpgrade","Title":"Natixis upgrades CCL to Neutral from Reduce.","DailyReturn":0.021025,"FiveDayReturnAfter":0.047225,"FiveDayReturnBefore":0.073888},{"Ticker":"CCL","EffectiveDate":"2013-12-19","Type":"EarningsRelease","Title":"Before market open, CCL reports 2013 Q4's earning $0.09 per share and revenue $3658MM..","DailyReturn":0.02533,"FiveDayReturnAfter":0.063427,"FiveDayReturnBefore":0.047741},{"Ticker":"CCL","EffectiveDate":"2013-12-19","Type":"RatingUpgrade","Title":"UBS upgrades CCL to Buy from Neutral.","DailyReturn":0.02533,"FiveDayReturnAfter":0.063427,"FiveDayReturnBefore":0.047741},{"Ticker":"CCL","EffectiveDate":"2013-12-06","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $41; previously $42.","DailyReturn":0.010003,"FiveDayReturnAfter":0.009952,"FiveDayReturnBefore":-0.033719},{"Ticker":"CCL","EffectiveDate":"2013-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.011029,"FiveDayReturnAfter":0.016826,"FiveDayReturnBefore":-0.001682},{"Ticker":"CCL","EffectiveDate":"2013-10-04","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on CCL to Reduce. Target Price is $26.","DailyReturn":0.002163,"FiveDayReturnAfter":-0.015573,"FiveDayReturnBefore":-0.01746},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Natixis downgrades CCL to Reduce from Neutral.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $39; previously $40.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CCL to Underweight from Equal-Weight. Target Price is $32.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Buy. Target Price is $40; previously $44.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Numis Securities downgrades CCL to Hold from Add.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Nomura maintains CCL to Neutral. Target Price is $32; previously $36.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Bank of America downgrades CCL to Neutral from Buy. Target Price is $38.5; previously $42.8.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $42; previously $44.","DailyReturn":-0.053272,"FiveDayReturnAfter":-0.058419,"FiveDayReturnBefore":-0.085418},{"Ticker":"CCL","EffectiveDate":"2013-09-24","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2013 Q3's earning $1.38 per share and revenue $4730MM. This beats analyst's estimated EPS $1.3, beats estimated revenue $4650MM.","DailyReturn":-0.076471,"FiveDayReturnAfter":-0.136132,"FiveDayReturnBefore":0.001606},{"Ticker":"CCL","EffectiveDate":"2013-09-04","Type":"RatingUpgrade","Title":"Susquehanna upgrades CCL to Positive from Neutral.","DailyReturn":-0.002779,"FiveDayReturnAfter":0.033077,"FiveDayReturnBefore":-0.040845},{"Ticker":"CCL","EffectiveDate":"2013-08-21","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.014481,"FiveDayReturnAfter":0.018213,"FiveDayReturnBefore":-0.011821},{"Ticker":"CCL","EffectiveDate":"2013-08-15","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CCL to Buy from Neutral. Target Price is $42; previously $31.","DailyReturn":-0.00596,"FiveDayReturnAfter":-0.006152,"FiveDayReturnBefore":-0.002435},{"Ticker":"CCL","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"Tigress Financial initiates coverage on CCL to Underperform.","DailyReturn":-0.000265,"FiveDayReturnAfter":-0.020902,"FiveDayReturnBefore":0.021441},{"Ticker":"CCL","EffectiveDate":"2013-07-30","Type":"RatingNeutral","Title":"Numis Securities downgrades CCL to Add from Buy.","DailyReturn":-0.001619,"FiveDayReturnAfter":0.01686,"FiveDayReturnBefore":0.014682},{"Ticker":"CCL","EffectiveDate":"2013-06-26","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $44; previously $40.","DailyReturn":-0.003153,"FiveDayReturnAfter":-0.000286,"FiveDayReturnBefore":0.016762},{"Ticker":"CCL","EffectiveDate":"2013-06-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2013 Q2's earning $0.09 per share and revenue $3500MM. This beats analyst's estimated EPS $0.06, misses estimated revenue $3560MM.","DailyReturn":0.050271,"FiveDayReturnAfter":0.042146,"FiveDayReturnBefore":-0.014347},{"Ticker":"CCL","EffectiveDate":"2013-06-13","Type":"RatingUpgrade","Title":"Numis Securities upgrades CCL to Buy from Add.","DailyReturn":0.036675,"FiveDayReturnAfter":0.033065,"FiveDayReturnBefore":0.016021},{"Ticker":"CCL","EffectiveDate":"2013-05-30","Type":"RatingNeutral","Title":"Exane BNP Paribas downgrades CCL to Underperform from Neutral.","DailyReturn":0.012387,"FiveDayReturnAfter":-0.027565,"FiveDayReturnBefore":-0.013802},{"Ticker":"CCL","EffectiveDate":"2013-05-22","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.015495,"FiveDayReturnAfter":-0.013802,"FiveDayReturnBefore":-0.04029},{"Ticker":"CCL","EffectiveDate":"2013-05-22","Type":"RatingNeutral","Title":"HSBC downgrades CCL to Neutral from Overweight.","DailyReturn":-0.015495,"FiveDayReturnAfter":-0.013802,"FiveDayReturnBefore":-0.04029},{"Ticker":"CCL","EffectiveDate":"2013-05-22","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $40; previously $42.","DailyReturn":-0.015495,"FiveDayReturnAfter":-0.013802,"FiveDayReturnBefore":-0.04029},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $40; previously $43.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Nomura maintains CCL to Neutral. Target Price is $36; previously $37.5.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"HSBC downgrades CCL to Neutral from Market Outperform. Target Price is $37.5; previously $44.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Neutral from Neutral. Target Price is $32; previously $34.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"RS Platou Markets maintains CCL to Neutral. Target Price is $33; previously $38.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"UBS downgrades CCL to Neutral from Buy.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"William Blair downgrades CCL to Market Perform from Outperform.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Wells Fargo downgrades CCL to Market Perform from Outperform.","DailyReturn":-0.042752,"FiveDayReturnAfter":-0.06052,"FiveDayReturnBefore":0.015119},{"Ticker":"CCL","EffectiveDate":"2013-04-22","Type":"RatingNeutral","Title":"Nomura downgrades CCL to Neutral from Buy.","DailyReturn":-0.006888,"FiveDayReturnAfter":0.031543,"FiveDayReturnBefore":-0.02192},{"Ticker":"CCL","EffectiveDate":"2013-03-19","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $40; previously $44.","DailyReturn":-0.020932,"FiveDayReturnAfter":-0.00829,"FiveDayReturnBefore":-0.049464},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $35; previously $38.5.","DailyReturn":-0.029471,"FiveDayReturnAfter":-0.026383,"FiveDayReturnBefore":-0.020391},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Neutral. Target Price is $34; previously $35.","DailyReturn":-0.029471,"FiveDayReturnAfter":-0.026383,"FiveDayReturnBefore":-0.020391},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Nomura maintains CCL to Buy. Target Price is $42; previously $46.","DailyReturn":-0.029471,"FiveDayReturnAfter":-0.026383,"FiveDayReturnBefore":-0.020391},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Exane BNP Paribas downgrades CCL to Neutral from Outperform.","DailyReturn":-0.029471,"FiveDayReturnAfter":-0.026383,"FiveDayReturnBefore":-0.020391},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $42; previously $47.","DailyReturn":-0.029471,"FiveDayReturnAfter":-0.026383,"FiveDayReturnBefore":-0.020391},{"Ticker":"CCL","EffectiveDate":"2013-03-15","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2013 Q1's earning $0.08 per share and revenue $3590MM. This beats analyst's estimated EPS $0.02, misses estimated revenue $3630MM.","DailyReturn":-0.02183,"FiveDayReturnAfter":-0.060572,"FiveDayReturnBefore":-0.014173},{"Ticker":"CCL","EffectiveDate":"2013-02-25","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Neutral. Target Price is $35; previously $36.","DailyReturn":-0.016005,"FiveDayReturnAfter":0.02428,"FiveDayReturnBefore":-0.0584},{"Ticker":"CCL","EffectiveDate":"2013-02-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.02289,"FiveDayReturnAfter":-0.045995,"FiveDayReturnBefore":-0.05877},{"Ticker":"CCL","EffectiveDate":"2013-01-14","Type":"RatingNeutral","Title":"Nomura maintains CCL to Buy. Target Price is $85; previously $75.","DailyReturn":0.009182,"FiveDayReturnAfter":0.041005,"FiveDayReturnBefore":-0.00081},{"Ticker":"CCL","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"UBS maintains CCL to Buy. Target Price is $43.37; previously $40.16.","DailyReturn":-0.003238,"FiveDayReturnAfter":-0.00081,"FiveDayReturnBefore":0.009761},{"Ticker":"CCL","EffectiveDate":"2012-12-24","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $38.5; previously $42.75.","DailyReturn":0.001621,"FiveDayReturnAfter":-0.006777,"FiveDayReturnBefore":-0.018731},{"Ticker":"CCL","EffectiveDate":"2012-12-20","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2012 Q4's earning $0.13 per share and revenue $3580MM. This beats analyst's estimated EPS $0.11, beats estimated revenue $3540MM.","DailyReturn":-0.052995,"FiveDayReturnAfter":-0.062322,"FiveDayReturnBefore":0.03094},{"Ticker":"CCL","EffectiveDate":"2012-12-19","Type":"RatingNeutral","Title":"RS Platou Markets maintains CCL to Neutral. Target Price is $44; previously $38.","DailyReturn":-0.006612,"FiveDayReturnAfter":-0.071684,"FiveDayReturnBefore":0.038102},{"Ticker":"CCL","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $47; previously $40.","DailyReturn":0.000528,"FiveDayReturnAfter":0.038102,"FiveDayReturnBefore":0.015173},{"Ticker":"CCL","EffectiveDate":"2012-12-05","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":-0.001878,"FiveDayReturnAfter":0.015173,"FiveDayReturnBefore":-0.008958},{"Ticker":"CCL","EffectiveDate":"2012-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.005001,"FiveDayReturnAfter":0.003416,"FiveDayReturnBefore":-0.005736},{"Ticker":"CCL","EffectiveDate":"2012-11-07","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $48; previously $46.","DailyReturn":-0.008211,"FiveDayReturnAfter":-0.014474,"FiveDayReturnBefore":0.029161},{"Ticker":"CCL","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $37; previously $34.","DailyReturn":-0.011254,"FiveDayReturnAfter":0.019033,"FiveDayReturnBefore":-0.026011},{"Ticker":"CCL","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Barclays initiates coverage on CCL to Equal-Weight.","DailyReturn":-0.011254,"FiveDayReturnAfter":0.019033,"FiveDayReturnBefore":-0.026011},{"Ticker":"CCL","EffectiveDate":"2012-09-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $38; previously $35.","DailyReturn":-0.007073,"FiveDayReturnAfter":-0.005182,"FiveDayReturnBefore":-0.025515},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Nomura maintains CCL to Buy. Target Price is $42; previously $40.","DailyReturn":-0.00863,"FiveDayReturnAfter":-0.0254,"FiveDayReturnBefore":-0.013661},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Jefferies downgrades CCL to Hold from Buy. Target Price is $37.5.","DailyReturn":-0.00863,"FiveDayReturnAfter":-0.0254,"FiveDayReturnBefore":-0.013661},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $36; previously $35.","DailyReturn":-0.00863,"FiveDayReturnAfter":-0.0254,"FiveDayReturnBefore":-0.013661},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $44; previously $42.","DailyReturn":-0.00863,"FiveDayReturnAfter":-0.0254,"FiveDayReturnBefore":-0.013661},{"Ticker":"CCL","EffectiveDate":"2012-09-25","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $40; previously $38.5.","DailyReturn":0.002162,"FiveDayReturnAfter":-0.026843,"FiveDayReturnBefore":-0.01715},{"Ticker":"CCL","EffectiveDate":"2012-09-25","Type":"EarningBeat","Title":"Before market open, CCL reports 2012 Q3's earning $1.53 per share and revenue $4680MM. This beats analyst's estimated EPS $1.44, meets estimated revenue $4680MM.","DailyReturn":0.002162,"FiveDayReturnAfter":-0.026843,"FiveDayReturnBefore":-0.01715},{"Ticker":"CCL","EffectiveDate":"2012-09-24","Type":"RatingNeutral","Title":"Topeka downgrades CCL to Hold from Buy. Target Price is $38.","DailyReturn":-0.010431,"FiveDayReturnAfter":-0.026011,"FiveDayReturnBefore":-0.01513},{"Ticker":"CCL","EffectiveDate":"2012-09-14","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $38.5; previously $37.5.","DailyReturn":0.003702,"FiveDayReturnAfter":-0.005834,"FiveDayReturnBefore":0.051266},{"Ticker":"CCL","EffectiveDate":"2012-08-22","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.007569,"FiveDayReturnAfter":0.018173,"FiveDayReturnBefore":0.017788},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"UBS maintains CCL to Buy. Target Price is $40; previously $39.","DailyReturn":-0.004753,"FiveDayReturnAfter":0.017962,"FiveDayReturnBefore":-0.032157},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $38; previously $30.","DailyReturn":-0.004753,"FiveDayReturnAfter":0.017962,"FiveDayReturnBefore":-0.032157},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $41; previously $35.","DailyReturn":-0.004753,"FiveDayReturnAfter":0.017962,"FiveDayReturnBefore":-0.032157},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $34; previously $30.","DailyReturn":-0.004753,"FiveDayReturnAfter":0.017962,"FiveDayReturnBefore":-0.032157},{"Ticker":"CCL","EffectiveDate":"2012-06-22","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2012 Q2's earning $0.2 per share and revenue $3500MM. This beats analyst's estimated EPS $0.08, misses estimated revenue $3550MM.","DailyReturn":-0.026605,"FiveDayReturnAfter":-0.024589,"FiveDayReturnBefore":0.000578},{"Ticker":"CCL","EffectiveDate":"2012-05-23","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.002203,"FiveDayReturnAfter":0.004397,"FiveDayReturnBefore":0.003441},{"Ticker":"CCL","EffectiveDate":"2012-03-12","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $36; previously $39.","DailyReturn":0.010141,"FiveDayReturnAfter":0.055668,"FiveDayReturnBefore":-0.000001},{"Ticker":"CCL","EffectiveDate":"2012-03-09","Type":"EarningsRelease","Title":"Before market open, CCL reports 2012 Q1's earning $-0.18 per share and revenue $3582MM..","DailyReturn":-0.012278,"FiveDayReturnAfter":0.045477,"FiveDayReturnBefore":0.014645},{"Ticker":"CCL","EffectiveDate":"2012-03-07","Type":"RatingNeutral","Title":"UBS maintains CCL to Buy. Target Price is $34; previously $35.","DailyReturn":0.032225,"FiveDayReturnAfter":0.083274,"FiveDayReturnBefore":-0.01782},{"Ticker":"CCL","EffectiveDate":"2012-03-01","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $30; previously $27.","DailyReturn":0.006933,"FiveDayReturnAfter":0.00461,"FiveDayReturnBefore":0.006292},{"Ticker":"CCL","EffectiveDate":"2012-02-22","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.012791,"FiveDayReturnAfter":-0.015869,"FiveDayReturnBefore":0.006853},{"Ticker":"CCL","EffectiveDate":"2012-02-08","Type":"RatingNeutral","Title":"Charles Stanley downgrades CCL to Hold from Accumulate.","DailyReturn":0.006606,"FiveDayReturnAfter":-0.043394,"FiveDayReturnBefore":0.05131}];